JP2008531701A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531701A5
JP2008531701A5 JP2007558123A JP2007558123A JP2008531701A5 JP 2008531701 A5 JP2008531701 A5 JP 2008531701A5 JP 2007558123 A JP2007558123 A JP 2007558123A JP 2007558123 A JP2007558123 A JP 2007558123A JP 2008531701 A5 JP2008531701 A5 JP 2008531701A5
Authority
JP
Japan
Prior art keywords
compound
amino
pharmaceutically acceptable
combination
sugar moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007558123A
Other languages
English (en)
Other versions
JP2008531701A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/007021 external-priority patent/WO2006093933A2/en
Publication of JP2008531701A publication Critical patent/JP2008531701A/ja
Publication of JP2008531701A5 publication Critical patent/JP2008531701A5/ja
Pending legal-status Critical Current

Links

Claims (4)

  1. 下記式:
    Figure 2008531701
    たは
    その薬学的に許容される塩、エスエル、溶媒和物、立体異性体、互変異性体もしくはプロドラッグ。
  2. 治療的有効量の請求項1記載の化合物を、薬学的に許容される担体と一緒に含む、医薬組成物。
  3. 抗菌学的有効量の請求項1記載の化合物と薬学的に許容される担体とを含む、抗菌治療を必要とする哺乳動物の治療のための組成物
  4. 転位バンコマイシンまたはデスメチル−バンコマイシン化合物:
    Figure 2008531701
    を、
    (a)該化合物のアミノ置換糖部分におけるアミノ置換基の、構造−C(=O)CR7aNR8aを有するアシル基によるアシル化、
    (b)該化合物のアミノ置換糖部分におけるアミノ置換基の、構造−C(=O)Rを有するアシル基によるアシル化、
    (c)該化合物のアミノ置換糖部分におけるアミノ置換基の、構造CHR5aを有するアルキル基によるアルキル化、
    (d)該化合物の大環状の環上の酸部分の、Rによって定義される置換アミドによる変換、
    (e)(a)と(d)との組み合わせ、
    (f)(b)と(d)との組み合わせ、
    (g)(c)と(d)との組み合わせ、
    からなる群から選択される技術によって修飾し、式:
    Figure 2008531701
    (式中、R、R、R、R、R、R5a、R、R、R7a、R、およびR8aは、本明細書で定義した意味を有する)
    を有する化合物を形成させることを含む、請求項1記載の化合物の製造方法。
JP2007558123A 2005-02-28 2006-02-27 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド Pending JP2008531701A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65763605P 2005-02-28 2005-02-28
PCT/US2006/007021 WO2006093933A2 (en) 2005-02-28 2006-02-27 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009035654A Division JP2009102445A (ja) 2005-02-28 2009-02-18 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド

Publications (2)

Publication Number Publication Date
JP2008531701A JP2008531701A (ja) 2008-08-14
JP2008531701A5 true JP2008531701A5 (ja) 2009-04-09

Family

ID=36941722

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007558123A Pending JP2008531701A (ja) 2005-02-28 2006-02-27 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド
JP2009035654A Pending JP2009102445A (ja) 2005-02-28 2009-02-18 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009035654A Pending JP2009102445A (ja) 2005-02-28 2009-02-18 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド

Country Status (7)

Country Link
US (2) US7368422B2 (ja)
EP (1) EP1858908A4 (ja)
JP (2) JP2008531701A (ja)
AU (1) AU2006218743A1 (ja)
BR (1) BRPI0607701A2 (ja)
CA (1) CA2599336A1 (ja)
WO (1) WO2006093933A2 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070092719A (ko) 2004-11-29 2007-09-13 고쿠리츠 다이가쿠 호우징 나고야 다이가쿠 글리코펩타이드 항생 물질 모노머 유도체
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
GB2449156B8 (en) * 2007-05-08 2010-06-02 Lead Therapeutics Inc Semi-synthetic glycopeptides with antibacterial activity.
WO2009085562A1 (en) * 2007-12-26 2009-07-09 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
US20100105607A1 (en) * 2008-10-24 2010-04-29 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
CN102713919B (zh) * 2009-11-13 2016-07-06 贝克曼考尔特公司 用于使用聚类来检测生物学状态的存在的系统和方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3568549D1 (en) * 1984-09-06 1989-04-13 Fujimori Kogyo Co Laminated film for packaging
US5500410A (en) * 1989-03-29 1996-03-19 Gruppo Lepetit S.P.A. Substituted alkylamide derivatives of teicoplanin
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5488131A (en) * 1994-03-23 1996-01-30 California Institute Of Technology Synthesis of compounds with predetermined chirality
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
CN1249081C (zh) * 1998-12-23 2006-04-05 施万制药 糖肽衍生物或含有它们的药物组合物
US6699836B2 (en) * 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
WO2000069893A1 (en) * 1999-05-19 2000-11-23 Merck & Co., Inc. Glycopeptide antibacterial compounds, compositions containing same and methods of using same
US20030008812A1 (en) * 2001-02-02 2003-01-09 Christensen Burton G. Glycopeptide derivatives
US7348309B2 (en) * 2001-03-30 2008-03-25 Wisconsin Alumni Research Foundation Glycorandomization and production of novel vancomycin analogs
AU2003260198A1 (en) 2002-08-30 2004-03-19 Chiron Corporation Glycopeptide antibiotic and semisynthetic derivatives thereof and their use as antiviral agents
US7273845B2 (en) * 2002-11-12 2007-09-25 Enzon Pharmaceuticals, Inc. Polymeric prodrugs of vancomycin
WO2004110473A1 (en) * 2003-05-27 2004-12-23 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity

Similar Documents

Publication Publication Date Title
JP2008531701A5 (ja)
JP2009504764A5 (ja)
WO2007138110A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
JP2008510770A5 (ja)
JP2007522220A5 (ja)
JP2009519243A5 (ja)
JP2009511508A5 (ja)
JP2006526031A5 (ja)
EP2682387A3 (en) C7-fluoro substituted tetracycline compounds
EP2457918A3 (en) Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes
JP2008531702A5 (ja)
WO2009082819A8 (en) Novel lupane derivatives
JP2008513510A5 (ja)
JP2010515731A5 (ja)
JP2006514012A5 (ja)
WO2009013348A3 (en) Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
JP2009513604A5 (ja)
WO2006125621A8 (en) Substituted piperidines as renin inhibitors
EP2404913A3 (en) Process and intermediates for the preparation of antitumoral dihydropyran-2-one compounds
JP2013514980A5 (ja)
WO2007002764A3 (en) Di-substituted oxadiazoles as cxc-chemokine receptor ligands
JP2008531713A5 (ja)
JP2018048191A (ja) 細菌感染症を治療するための方法および組成物
JP2007500222A5 (ja)
JP2010514734A5 (ja)